Rajesh Malik - Net Worth and Insider Trading
Rajesh Malik Net Worth
The estimated net worth of Rajesh Malik is at least $724,303 dollars as of 2024-04-27. Rajesh Malik is the Chief Medical Officer of G1 Therapeutics Inc and owns about 169,938 shares of G1 Therapeutics Inc (GTHX) stock worth over $678,053. Rajesh Malik is also the Director of POINT Biopharma Global Inc and owns about 3,700 shares of POINT Biopharma Global Inc (PNT) stock worth over $46,250. Details can be seen in Rajesh Malik's Latest Holdings Summary section.
Disclaimer: The insider information is derived from SEC filings. The estimated net worth is based on the assumption that Rajesh Malik has not made any transactions after 2024-02-12 and currently still holds the listed stock(s).
Transaction Summary of Rajesh Malik
Rajesh Malik Insider Ownership Reports
Based on ownership reports from SEC filings, as the reporting owner, Rajesh Malik owns 2 companies in total, including G1 Therapeutics Inc (GTHX) , and POINT Biopharma Global Inc (PNT) .
Click here to see the complete history of Rajesh Malik’s form 4 insider trades.
Insider Ownership Summary of Rajesh Malik
| Ticker | Comapny | Transaction Date | Type of Owner |
|---|---|---|---|
| GTHX | G1 Therapeutics Inc | 2024-02-12 | Chief Medical Officer |
| PNT | POINT Biopharma Global Inc | 2022-11-28 | director |
Rajesh Malik Latest Holdings Summary
Rajesh Malik currently owns a total of 2 stocks. Among these stocks, Rajesh Malik owns 169,938 shares of G1 Therapeutics Inc (GTHX) as of February 12, 2024, with a value of $678,053 and a weighting of 93.61%. Rajesh Malik also owns 3,700 shares of POINT Biopharma Global Inc (PNT) as of November 28, 2022, with a value of $46,250 and a weighting of 6.39%.
Latest Holdings of Rajesh Malik
| Ticker | Comapny | Latest Transaction Date | Shares Owned | Current Price ($) | Current Value ($) |
|---|---|---|---|---|---|
| GTHX | G1 Therapeutics Inc | 2024-02-12 | 169,938 | 3.99 | 678,053 |
| PNT | POINT Biopharma Global Inc | 2022-11-28 | 3,700 | 12.50 | 46,250 |
Holding Weightings of Rajesh Malik
Rajesh Malik Form 4 Trading Tracker
According to the SEC Form 4 filings, Rajesh Malik has made a total of 13 transactions in G1 Therapeutics Inc (GTHX) over the past 5 years, including 0 buys and 13 sells. The most-recent trade in G1 Therapeutics Inc is the sale of 28,600 shares on February 12, 2024, which brought Rajesh Malik around $132,132.
According to the SEC Form 4 filings, Rajesh Malik has made a total of 1 transactions in POINT Biopharma Global Inc (PNT) over the past 5 years, including 1 buys and 0 sells. The most-recent trade in POINT Biopharma Global Inc is the acquisition of 3,700 shares on November 28, 2022, which cost Rajesh Malik around $24,642.
Insider Trading History of Rajesh Malik
- 1
Rajesh Malik Trading Performance
GuruFocus tracks the stock performance after each of Rajesh Malik's buying transactions within different timeframes. To be detailed, the average return of stocks after 3 months bought by Rajesh Malik is 13.66%. GuruFocus also compares Rajesh Malik's trading performance to market benchmark return within the same time period. The performance of stocks bought by Rajesh Malik within 3 months outperforms 1 times out of 1 transactions in total compared to the return of S&P 500 within the same period.
You can select different timeframes to see how Rajesh Malik's insider trading performs compared to the benchmark.
Performance of Rajesh Malik
Average Return
109.56%
Outperforming Transactions
100%
| 1 Month | 3 Months | 6 Months | 1 Year | 2 Years | 3 Years | |
|---|---|---|---|---|---|---|
| Return(%) | 2.43 | 13.66 | 42.79 | 109.56 | ||
| Relative Return to S&P 500(%) | 6.99 | 13.5 | 36.7 | 94.65 |
Rajesh Malik Ownership Network
Ownership Network List of Rajesh Malik
Ownership Network Relation of Rajesh Malik
Rajesh Malik Owned Company Details
What does G1 Therapeutics Inc do?
Who are the key executives at G1 Therapeutics Inc?
Rajesh Malik is the Chief Medical Officer of G1 Therapeutics Inc. Other key executives at G1 Therapeutics Inc include Chief Financial Officer John V. Umstead , Chief Business Officer Mark Avagliano , and Chief Operating Officer Terry L Murdock .
G1 Therapeutics Inc (GTHX) Insider Trades Summary
Over the past 18 months, Rajesh Malik made 5 insider transaction in G1 Therapeutics Inc (GTHX) with a net sale of 69,908. Other recent insider transactions involving G1 Therapeutics Inc (GTHX) include a net sale of 85,014 shares made by Bailey John E. (jack) Jr. , a net sale of 7,469 shares made by Terry L Murdock , and a net sale of 3,588 shares made by Andrew Perry .
In summary, during the past 3 months, insiders sold 35,147 shares of G1 Therapeutics Inc (GTHX) in total and bought 0 shares, with a net sale of 35,147 shares. During the past 18 months, 242,086 shares of G1 Therapeutics Inc (GTHX) were sold and 0 shares were bought by its insiders, resulting in a net sale of 242,086 shares.
G1 Therapeutics Inc (GTHX)'s detailed insider trading history can be found in Insider Trading Tracker table.
G1 Therapeutics Inc Insider Transactions
Rajesh Malik Mailing Address
Above is the net worth, insider trading, and ownership report for Rajesh Malik. You might contact Rajesh Malik via mailing address: 79 Tw Alexander Drive, 4501 Research Commons, Suite 100, Research Triangle Park Nc 27709.
We'd love to learn more about your experiences on GuruFocus.com and how we can improve!
Take Survey
